plus extended-release dipyridamole (200 mg) given twice daily, or clopidogrel (75 mg) given once daily. The study was sponsored by the maker of the aspirin/dipyridamole combination (Aggrenox).

A post hoc analysis revealed that the long-term benefits of clopidogrel over aspirin after PCI were most evident in patients ...

or clopidogrel 300–600 mg loading dose, 75 mg daily thereafter). During the 12-month follow-up period, the primary end point of death from cardiovascular causes, MI, or stroke was significantly ...

Major or minor bleeding events were detected in 8.1% of the clopidogrel group, 9.8% of the group receiving 90 mg AZD6140, and 8.0% of the group receiving 180 mg AZD6140. Within these groups ...